|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.20 USD | +1.05% |
|
+1.53% | +22.84% |
| 02-12 | Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… | |
| 02-06 | Markets Ask the Obvious Question |
| Capitalization | 6.92B 5.83B 5.32B 5.08B 9.42B 627B 9.79B 61.86B 24.56B 303B 25.95B 25.42B 1,058B | P/E ratio 2026 * |
18.7x | P/E ratio 2027 * | 15.5x |
|---|---|---|---|---|---|
| Enterprise value | 6.98B 5.88B 5.37B 5.12B 9.51B 632B 9.88B 62.41B 24.78B 305B 26.18B 25.64B 1,067B | EV / Sales 2026 * |
0.81x | EV / Sales 2027 * | 0.76x |
| Free-Float |
99.37% | Yield 2026 * |
1.69% | Yield 2027 * | 1.73% |
Last Transcript: NOV Inc.
| 1 day | +1.05% | ||
| 1 week | +1.53% | ||
| Current month | +4.63% | ||
| 1 month | +8.35% | ||
| 3 months | +25.74% | ||
| 6 months | +55.59% | ||
| Current year | +22.84% |
| 1 week | 18.48 | 19.6 | |
| 1 month | 17.55 | 19.6 | |
| Current year | 15.6 | 19.6 | |
| 1 year | 10.84 | 19.6 | |
| 3 years | 10.84 | 23.44 | |
| 5 years | 10.84 | 24.83 | |
| 10 years | 7.7 | 49.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jose Bayardo
CEO | Chief Executive Officer | 54 | 01/01/2026 |
Rodney Reed
DFI | Director of Finance/CFO | 45 | 17/03/2025 |
Alex Philips
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Ben Guill
BRD | Director/Board Member | 75 | 01/01/1999 |
David Harrison
BRD | Director/Board Member | 79 | 01/08/2003 |
Marcela Donadio
BRD | Director/Board Member | 71 | 08/04/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.05% | +1.53% | +20.53% | -19.87% | 6.92B | ||
| +0.30% | +5.45% | +43.37% | +133.85% | 7.69B | ||
| -11.00% | -5.93% | +259.77% | +895.49% | 6.42B | ||
| -3.57% | +0.47% | +8.82% | +33.33% | 6.36B | ||
| +0.27% | +1.70% | +65.28% | +110.27% | 5.96B | ||
| +2.80% | +1.90% | +18.46% | +241.99% | 5.73B | ||
| -1.24% | -1.48% | -2.93% | +30.88% | 5.02B | ||
| -0.21% | -1.84% | -5.29% | +6.17% | 3.92B | ||
| +0.68% | +0.95% | -6.14% | +26.61% | 3.75B | ||
| -0.37% | -1.45% | -1.81% | - | 3.69B | ||
| Average | -1.13% | +0.20% | +40.01% | +162.08% | 5.55B | |
| Weighted average by Cap. | -1.30% | +0.48% | +47.40% | +177.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.65B 7.29B 6.65B 6.35B 11.78B 783B 12.24B 77.31B 30.69B 378B 32.43B 31.77B 1,322B | 8.93B 7.52B 6.86B 6.55B 12.16B 809B 12.64B 79.82B 31.69B 391B 33.49B 32.8B 1,365B |
| Net income | 371M 312M 285M 272M 505M 33.58B 525M 3.31B 1.32B 16.22B 1.39B 1.36B 56.67B | 437M 368M 336M 320M 595M 39.54B 618M 3.9B 1.55B 19.09B 1.64B 1.6B 66.74B |
| Net Debt | 62M 52.24M 47.65M 45.49M 84.44M 5.62B 87.74M 554M 220M 2.71B 233M 228M 9.48B | -128M -108M -98.12M -93.67M -174M -11.56B -181M -1.14B -453M -5.58B -479M -469M -19.52B |
Employees
31,605
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/02/26 | 19.20 $ | +1.05% | 5,185,606 |
| 12/02/26 | 19.00 $ | -2.41% | 4,570,151 |
| 11/02/26 | 19.47 $ | +4.85% | 5,369,631 |
| 10/02/26 | 18.57 $ | -2.06% | 3,475,726 |
| 09/02/26 | 18.96 $ | +0.26% | 5,515,668 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
19.20USD
Average target price
19.36USD
Spread / Average Target
+0.83%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















